Cadila Healthcare Gains On CLSA Upgrade

Gold Silver Reports (GSR) – Cadila Healthcare Gains On CLSA Upgrade — Shares of the Ahmedabad-based drug maker rose as much as 3.3 percent, the most in over a month, to Rs 382.55 after CLSA upgraded the stock to ‘Buy’ from ‘Underperform’ and raised its target price to Rs 450 from Rs 440.

Read more →